← Back to Search

SUMMIT Tool for Chronic Pain

Phase 2 & 3

Waitlist Available

Led By William C Becker, MD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 9-months

Awards & highlights

Study Summary

This trial is testing a mobile website to help veterans with chronic pain safely taper opioids while managing their pain.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 9-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~9-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 9-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

opioid dose

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: SUMMITExperimental Treatment1 Intervention

Participants randomized to the experimental intervention will participate in a Motivational Interviewing (MI) session lasting between 30 and 60 minutes with study psychologist. All MI sessions will be audiotaped using a VA-approved digital recorder and transcribed verbatim. Participants will subsequently be shown how to access SUMMIT via a set of unique anonymized login credentials and to navigate the components of SUMMIT on one or more devices, depending on their preference. They will then be trained on how to complete the outcome surveys.

Group II: controlPlacebo Group1 Intervention

Participants randomized to the control intervention will use an eHealth comparator: My Pain Diary: Chronic Pain Management (iPhone, Android). This app includes a pain monitoring functioning only, and thus will only minimally overlap, if at all, with SUMMIT's components. Control participants will not participate in a MI session. Participants will download the app and be shown how to use the My Pain Diary app and trained how to complete the outcome surveys

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

SUMMIT

2021

Completed Phase 3

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor

1,609 Previous Clinical Trials

3,306,559 Total Patients Enrolled

39 Trials studying Chronic Pain

4,713 Patients Enrolled for Chronic Pain

William C Becker, MDPrincipal InvestigatorVA Connecticut Healthcare System West Haven Campus, West Haven, CT

2 Previous Clinical Trials

4,841 Total Patients Enrolled

1 Trials studying Chronic Pain

7 Patients Enrolled for Chronic Pain

Media Library

control Clinical Trial Eligibility Overview. Trial Name: NCT04746833 — Phase 2 & 3

Chronic Pain Research Study Groups: control, SUMMIT

Chronic Pain Clinical Trial 2023: control Highlights & Side Effects. Trial Name: NCT04746833 — Phase 2 & 3

control 2023 Treatment Timeline for Medical Study. Trial Name: NCT04746833 — Phase 2 & 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are we still enrolling people in this experiment?

"From the looks of the most recent update on clinicaltrials.gov, this trial is still looking for participants. The listing was originally posted on March 24th, 2021 and was updated as recently as October 7th, 2022."

Answered by AI

How many people can join this clinical trial at the most?

"This is correct. The information on clinicaltrials.gov does show that this study is actively recruiting patients. The study was first posted on 2021-03-24, and was last updated on 2022-10-07. The study is looking for 64 patients across 2 sites."

Answered by AI